Elanco Animal Health Inc (NYSE:ELAT – Get Rating) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 10,100 shares, an increase of 102.0% from the December 31st total of 5,000 shares. Based on an average daily trading volume, of 21,100 shares, the days-to-cover ratio is currently 0.5 days.
Elanco Animal Health Stock Performance
Shares of Elanco Animal Health stock traded up $0.30 on Friday, reaching $21.82. 104,834 shares of the company were exchanged, compared to its average volume of 43,269. Elanco Animal Health has a 1-year low of $17.98 and a 1-year high of $45.08. The stock's 50 day moving average price is $20.06 and its 200-day moving average price is $23.29.
Get
Elanco Animal Health alerts:
Elanco Animal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 1st. Stockholders of record on Friday, January 13th will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a dividend yield of 11.46%. The ex-dividend date is Thursday, January 12th.
Hedge Funds Weigh In On Elanco Animal Health
A number of institutional investors and hedge funds have recently made changes to their positions in ELAT. Jane Street Group LLC acquired a new position in Elanco Animal Health in the first quarter valued at approximately $391,000. Elequin Capital LP acquired a new position in Elanco Animal Health in the third quarter valued at approximately $5,026,000. Palisade Capital Management LLC NJ boosted its holdings in Elanco Animal Health by 29.8% in the third quarter. Palisade Capital Management LLC NJ now owns 39,251 shares of the company's stock valued at $807,000 after purchasing an additional 9,000 shares in the last quarter. Penn Mutual Asset Management LLC acquired a new position in Elanco Animal Health in the third quarter valued at approximately $247,000. Finally, BlueCrest Capital Management Ltd boosted its holdings in Elanco Animal Health by 321.5% in the third quarter. BlueCrest Capital Management Ltd now owns 37,935 shares of the company's stock valued at $793,000 after purchasing an additional 28,936 shares in the last quarter.
Featured Articles
- Get a free copy of the StockNews.com research report on Elanco Animal Health (ELAT)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
